FDA Adverse Event Malfunction Summary report: N

ELECSYS DHEA-S

MDR report key: 20668217 · Received November 12, 2024

Report

Report Number
1823260-2024-03284
Event Type
Malfunction
Date Received
November 12, 2024
Date of Event
October 21, 2024
Report Date
January 3, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JKC
UDI-DI
04015630940387
PMA / PMN Number
K003174
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE E801 ANALYZER SERIAL NUMBER WAS (B)(6). SAMPLE MATERIAL WAS REQUESTED FOR INVESTIGATION.

Additional Manufacturer Narrative · 0

CALIBRATION AND QC WERE ACCEPTABLE. SAMPLE MATERIAL WAS RECEIVED FOR INVESTIGATION. FURTHER INVESTIGATION OF THE PATIENT SAMPLE SUGGESTS THE PRESENCE OF AN INTERFERENT AGAINST THE STREPTAVIDIN COMPONENT OF THE REAGENT. THIS INTERFERENCE IS COVERED IN PRODUCT LABELING: "IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN." THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Description of Event or Problem · 0

THE INITIAL REPORTER COMPLAINED OF DISCREPANT HIGH RESULTS FOR 1 PATIENT TESTED FOR ELECSYS DHEA-S (DHEA-S) ON A COBAS E 801 ANALYTICAL UNIT COMPARED TO THE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (LC-MS) METHOD. THE INITIAL RESULT WAS >1000 UG/DL. THE SAMPLE WAS REPEATED "SEVERAL" TIMES AND THE RESULTS REMAINED >1000 UG/DL. THE HIGH RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. DUE TO THE HIGH RESULTS, REPEAT TESTING BY LC-MS WAS REQUESTED. THE RESULT FROM THE LC-MS METHOD WAS 382.54 UG/DL. THIS RESULT WAS BELIEVED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1643853 ELECSYS DHEA-S DEHYDROEPIANDROSTERONE TEST SYSTEM JKC ROCHE DIAGNOSTICS 79099701 04015630940387

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown